# CYP11A1

## Overview
CYP11A1 is a gene that encodes the enzyme cytochrome P450 family 11 subfamily A member 1, also known as cytochrome P450scc. This enzyme is a member of the cytochrome P450 superfamily, which is characterized by its role in catalyzing monooxygenase reactions. CYP11A1 is primarily located in the inner mitochondrial membrane and is pivotal in the biosynthesis of steroid hormones. It initiates the conversion of cholesterol to pregnenolone, the first and rate-limiting step in steroidogenesis, through its 20- and 22-hydroxylase and 20,22 desmolase activities (Guo2007Transcriptional; Slominski2021The). The enzyme is expressed in various tissues, including the adrenal cortex, gonads, and brain, where it contributes to local steroid production and the metabolism of sterols such as vitamin D (Slominski2014The; Slominski2021The). Mutations in the CYP11A1 gene can lead to disorders such as primary adrenal insufficiency and congenital lipoid adrenal hyperplasia, highlighting its essential role in endocrine function (al2006Homozygous; Goursaud2018Aberrant).

## Structure
CYP11A1, also known as cytochrome P450 11A1, is a protein located in the inner mitochondrial membrane and plays a crucial role in steroid synthesis. The mature protein consists of 521 amino acids, including a 39-amino acid signal peptide that is cleaved upon mitochondrial entry (Rosal2022The). The secondary structure of CYP11A1 includes 12 helices (A to L), four β-sheets, and loops between these structures. The A'-helix, located at amino acids 57-68, is hydrophobic and significant for membrane insertion and crista remodeling (Rosal2022The).

The tertiary structure of CYP11A1 involves a heme-binding domain, which is essential for its enzymatic activity. The interaction with adrenodoxin (Adx) is facilitated by specific lysine and arginine residues, such as K403, K405, and R426, which are crucial for binding and electron transfer (Usanov2002Probing). The quaternary structure involves the formation of a complex with Adx and adrenodoxin reductase, optimizing electron transfer for cholesterol conversion (Strushkevich2011Structural).

CYP11A1's structure is characterized by conserved interaction interfaces, suggesting a common mechanism among mitochondrial P450s (Strushkevich2011Structural). The protein's ability to remodel mitochondrial cristae is linked to its interaction with the MICOS complex and Hsp60, indicating a role beyond its enzymatic function (Rosal2022The).

## Function
CYP11A1, also known as cytochrome P450scc, is a crucial enzyme in steroidogenesis, catalyzing the conversion of cholesterol to pregnenolone. This reaction is the first and rate-limiting step in the synthesis of steroid hormones, occurring in the inner mitochondrial membrane of steroid-producing cells (Guo2007Transcriptional; Slominski2021The). The enzyme exhibits three enzymatic activities: 20- and 22-hydroxylase activities, which hydroxylate cholesterol at carbon-20 and carbon-22, and 20,22 desmolase activity, which cleaves the carbon 20-22 bond to produce pregnenolone and isocaproaldehyde (Guo2007Transcriptional).

CYP11A1 is expressed in various tissues, including the adrenal cortex, testis, ovary, placenta, brain, skin, and other non-classical steroidogenic tissues, where it plays a role in local steroidogenesis and the metabolism of vitamin D and other sterols (Slominski2014The; Slominski2021The). In the skin, CYP11A1 is involved in the metabolism of vitamin D, lumisterol, and 7-dehydrocholesterol, contributing to the maintenance of the protective barrier and immune functions (Slominski2021The). The enzyme's activity is regulated by several factors, including the StAR protein, cholesterol levels, and various signaling molecules (Slominski2021The). Defects in CYP11A1 can lead to primary adrenal insufficiency and congenital lipoid adrenal hyperplasia (Slominski2021The).

## Clinical Significance
Mutations in the CYP11A1 gene can lead to a variety of disorders, primarily affecting steroidogenesis. These include primary adrenal insufficiency (PAI), severe disorders of sex development (DSD), and familial glucocorticoid deficiency. Specific variants such as p.Arg465Trp and p.Arg120Gln have been associated with severe phenotypes, including early onset of PAI and severe DSD (Goursaud2018Aberrant). The p.Glu314Lys variant, although often predicted to be benign, has been linked to CYP11A1 deficiency when found in trans with a pathogenic mutation (Goursaud2018Aberrant).

CYP11A1 mutations can also cause congenital lipoid adrenal hyperplasia (CLAH), characterized by impaired production of adrenal and gonadal steroids, leading to severe salt-losing syndrome and phenotypic female characteristics in affected individuals (al2006Homozygous). In some cases, mutations result in severe combined adrenal and gonadal deficiency, as seen in patients with novel mutations leading to disorders of sex development and adrenal failure (Kim2008Severe).

Alterations in CYP11A1 expression or function can also affect metabolic traits and testosterone levels, contributing to conditions like polycystic ovary syndrome (PCOS) and infertility (Heidarzadehpilehrood2022A). These mutations and alterations underscore the critical role of CYP11A1 in maintaining normal steroid hormone biosynthesis and endocrine function.

## Interactions
CYP11A1 interacts primarily with adrenodoxin (Adx) and adrenodoxin reductase (AdR) to facilitate electron transfer necessary for its enzymatic activity. The interaction between CYP11A1 and Adx is characterized by high affinity, with a dissociation constant (Kd) of approximately 10 nM, which is crucial for the efficient electron transfer required for cholesterol conversion to pregnenolone (Yablokov2019A). This interaction is primarily driven by electrostatic forces, involving salt bridges between specific amino acids such as Lys339 and Asp72, and Lys343 and Asp76 (Zhu2017Active).

The presence of cholesterol as a substrate enhances the formation of the CYP11A1-Adx complex by increasing the association rate constant (kon), thereby strengthening the interaction. In contrast, other substrates like 25-hydroxycholesterol and 20S-hydroxycholesterol result in weaker interactions, as indicated by decreased kon and increased Kd values (Yablokov2021Substrateinduced). The interaction with Adx is essential for the catalytic cycle of CYP11A1, as it affects the reduction potential and facilitates the necessary electron transfer for the enzymatic reactions (Zhu2017Active). These protein-protein interactions are critical for the regulation of steroid hormone biosynthesis.


## References


[1. (Yablokov2019A) Evgeniy O. Yablokov, Tatsiana A. Sushko, Pavel V. Ershov, Anna V. Florinskaya, Oksana V. Gnedenko, Tatsiana V. Shkel, Irina P. Grabovec, Natallia V. Strushkevich, Leonid A. Kaluzhskiy, Sergey A. Usanov, Andrei A. Gilep, and Alexis S. Ivanov. A large-scale comparative analysis of affinity, thermodynamics and functional characteristics of interactions of twelve cytochrome p450 isoforms and their redox partners. Biochimie, 162:156–166, July 2019. URL: http://dx.doi.org/10.1016/j.biochi.2019.04.020, doi:10.1016/j.biochi.2019.04.020. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.biochi.2019.04.020)

[2. (al2006Homozygous) Hessa al Kandari, Noriyuki Katsumata, Suzan Alexander, and Majedah Abdul Rasoul. Homozygous mutation of p450 side-chain cleavage enzyme gene (cyp11a1) in 46, xy patient with adrenal insufficiency, complete sex reversal, and agenesis of corpus callosum. The Journal of Clinical Endocrinology &amp; Metabolism, 91(8):2821–2826, August 2006. URL: http://dx.doi.org/10.1210/jc.2005-2230, doi:10.1210/jc.2005-2230. This article has 52 citations.](https://doi.org/10.1210/jc.2005-2230)

[3. (Usanov2002Probing) Sergey A. Usanov, Sandra E. Graham, Galina I. Lepesheva, Tamara N. Azeva, Natalya V. Strushkevich, Andrei A. Gilep, Ronald W. Estabrook, and Julian A. Peterson. Probing the interaction of bovine cytochrome p450scc (cyp11a1) with adrenodoxin: evaluating site-directed mutations by molecular modeling. Biochemistry, 41(26):8310–8320, June 2002. URL: http://dx.doi.org/10.1021/bi0255928, doi:10.1021/bi0255928. This article has 57 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi0255928)

[4. (Rosal2022The) Karen G. Rosal, Wei-Yi Chen, and Bon-chu Chung. The a’-helix of cyp11a1 remodels mitochondrial cristae. Journal of Biomedical Science, August 2022. URL: http://dx.doi.org/10.1186/s12929-022-00846-7, doi:10.1186/s12929-022-00846-7. This article has 3 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/s12929-022-00846-7)

[5. (Kim2008Severe) Chan Jong Kim, Lin Lin, Ningwu Huang, Charmian A. Quigley, Theodore W. AvRuskin, John C. Achermann, and Walter L. Miller. Severe combined adrenal and gonadal deficiency caused by novel mutations in the cholesterol side chain cleavage enzyme, p450scc. The Journal of Clinical Endocrinology &amp; Metabolism, 93(3):696–702, March 2008. URL: http://dx.doi.org/10.1210/jc.2007-2330, doi:10.1210/jc.2007-2330. This article has 104 citations.](https://doi.org/10.1210/jc.2007-2330)

[6. (Slominski2014The) Andrzej T. Slominski, Tae-Kang Kim, Wei Li, Ae-Kyung Yi, Arnold Postlethwaite, and Robert C. Tuckey. The role of cyp11a1 in the production of vitamin d metabolites and their role in the regulation of epidermal functions. The Journal of Steroid Biochemistry and Molecular Biology, 144:28–39, October 2014. URL: http://dx.doi.org/10.1016/j.jsbmb.2013.10.012, doi:10.1016/j.jsbmb.2013.10.012. This article has 127 citations.](https://doi.org/10.1016/j.jsbmb.2013.10.012)

[7. (Goursaud2018Aberrant) Claire Goursaud, Delphine Mallet, Alexandre Janin, Rita Menassa, Véronique Tardy-Guidollet, Gianni Russo, Anne Lienhardt-Roussie, Claudine Lecointre, Ingrid Plotton, Yves Morel, and Florence Roucher-Boulez. Aberrant splicing is the pathogenicity mechanism of the p.glu314lys variant in cyp11a1 gene. Frontiers in Endocrinology, September 2018. URL: http://dx.doi.org/10.3389/fendo.2018.00491, doi:10.3389/fendo.2018.00491. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fendo.2018.00491)

[8. (Slominski2021The) R.M. Slominski, C. Raman, C. Elmets, A.M. Jetten, A.T. Slominski, and R.C. Tuckey. The significance of cyp11a1 expression in skin physiology and pathology. Molecular and Cellular Endocrinology, 530:111238, June 2021. URL: http://dx.doi.org/10.1016/j.mce.2021.111238, doi:10.1016/j.mce.2021.111238. This article has 66 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.mce.2021.111238)

[9. (Strushkevich2011Structural) Natallia Strushkevich, Farrell MacKenzie, Tatyana Cherkesova, Irina Grabovec, Sergey Usanov, and Hee-Won Park. Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system. Proceedings of the National Academy of Sciences, 108(25):10139–10143, June 2011. URL: http://dx.doi.org/10.1073/pnas.1019441108, doi:10.1073/pnas.1019441108. This article has 271 citations.](https://doi.org/10.1073/pnas.1019441108)

[10. (Heidarzadehpilehrood2022A) Roozbeh Heidarzadehpilehrood, Maryam Pirhoushiaran, Rasoul Abdollahzadeh, Malina Binti Osman, Maryam Sakinah, Norshariza Nordin, and Habibah Abdul Hamid. A review on cyp11a1, cyp17a1, and cyp19a1 polymorphism studies: candidate susceptibility genes for polycystic ovary syndrome (pcos) and infertility. Genes, 13(2):302, February 2022. URL: http://dx.doi.org/10.3390/genes13020302, doi:10.3390/genes13020302. This article has 57 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes13020302)

[11. (Yablokov2021Substrateinduced) E.O. Yablokov, T.A. Sushko, L.A. Kaluzhskiy, A.A. Kavaleuski, Y.V. Mezentsev, P.V. Ershov, A.A. Gilep, А.S. Ivanov, and N.V. Strushkevich. Substrate-induced modulation of protein-protein interactions within human mitochondrial cytochrome p450-dependent system. The Journal of Steroid Biochemistry and Molecular Biology, 208:105793, April 2021. URL: http://dx.doi.org/10.1016/j.jsbmb.2020.105793, doi:10.1016/j.jsbmb.2020.105793. This article has 13 citations.](https://doi.org/10.1016/j.jsbmb.2020.105793)

[12. (Zhu2017Active) Qianhong Zhu, Piotr J. Mak, Robert C. Tuckey, and James R. Kincaid. Active site structures of cyp11a1 in the presence of its physiological substrates and alterations upon binding of adrenodoxin. Biochemistry, 56(43):5786–5797, October 2017. URL: http://dx.doi.org/10.1021/acs.biochem.7b00766, doi:10.1021/acs.biochem.7b00766. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/acs.biochem.7b00766)

[13. (Guo2007Transcriptional) Ing-Cherng Guo, Meng-Chun Shih, Hsin-Chieh Lan, Nai-Chi Hsu, Meng-Chun Hu, and Bon-chu Chung. Transcriptional regulation of human cyp11a1 in gonads and adrenals. Journal of Biomedical Science, 14(4):509–515, June 2007. URL: http://dx.doi.org/10.1007/s11373-007-9177-z, doi:10.1007/s11373-007-9177-z. This article has 40 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s11373-007-9177-z)